Ann: G Medical Continues Rapid Growth in USA, page-153

In November 2019, the Company entered into a capital commitment agreement (hereinafter the "GEM Agreement"), with GEM Global Yield Fund LLC SCS and GEM Yield Bahamas Ltd (together "GEM"). The GEM agreement secures a capital equity line of up to AUD 30 million from GEM. In addition, according to the GEM Agreement, the Company issued to GEM warrants to purchase 25,000,000 ordinary shares at an exercise price of AUD 0.265 per share. The warrants will expire on November 29, 2024. In 2020 and 2019, the Company issued 12,500,000 and 12,500,000 warrants in two batches, at an exercise price of AUD 0.265. During the six-month period ended June 30, 2020, the Company issued 18,254,273 ordinary shares to GEM pursuant to the terms of the GEM agreement and utilized AUD 1,270 thousand (approximately $840). Upon issuance, the Company deducted the prepaid fees from equity.

3 days of trading left. Place your bets